Heterogeneous expression of the cholecystokinin-like immunoreactivity in the mouse hippocampus, with special reference to the dorsoventral difference

Neuroscience

Volumn 122, Issue 4, 2003, Pages 869-884

  Jinno, S ^a   Kosaka, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Granule cell; Molecular layer; Mossy fiber pathway; Mossy terminal; Postnatal development; Synaptoporin

Indexed keywords

CHOLECYSTOKININ; GLUTAMIC ACID; PROTEIN; SYNAPTOPORIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MOSSY FIBER; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; THREE DIMENSIONAL IMAGING;

EID: 0344010050     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.08.039     Document Type: Article

References (53)

1. Acsady L., Kamondi A., Sik A., Freund T., Buzsaki G. GABAergic cells are the major postsynaptic targets of mossy fibers in the rat hippocampus. J Neurosci. 18:1998;3386-3403.
2. Akaike K., Tanaka S., Tojo H., Fukumoto S., Imamura S., Takigawa M. Kainic acid-induced dorsal and ventral hippocampal seizures in rats. Brain Res. 900:2001;65-71.
3. Becher A., Drenckhahn A., Pahner I., Margittai M., Jahn R., Ahnert-Hilger G. The synaptophysin-synaptobrevin complex: a hallmark of synaptic vesicle maturation. J Neurosci. 19(6):1999;1922-1931.
4. Belleroche J., Bandopadhyay R., King A., Malcolm A.D., O'Brien K., Premi B.P., Rashid A. Regional distribution of cholecystokinin messenger RNA in rat brain during developments quantitation and correlation with cholecystokinin immunoreactivity. Neuropeptides. 15(4):1990;201-212.
5. Blasco-Ibanez J.M., Freund T.F. Distribution, ultrastructure, and connectivity of calretinin-immunoreactive mossy cells of the mouse dentate gyrus. Hippocampus. 7:1997;307-320.
6. Bohme G.A., Stutzmann J.M., Blanchard J.C. Excitatory effects of cholecystokinin in rat hippocampus: pharmacological response compatible with 'central'- or B-type CCK receptors. Brain Res. 451(1-2):1998;309-318.
7. Breukel A.I., Lopes da Silva F.H., Ghijsen W.E. Cholecystokinin (CCK-8) modulates vesicular release of excitatory amino acids in rat hippocampal nerve endings. Neurosci Lett. 234:1997;67-70.
8. Chandy J., Pierce J.P., Milner T.A. Rat hippocampal mossy fibers contain cholecystokinin-like immunoreactivity. Anat Rec. 243:1995;519-523.
9. Cope D.W., Maccaferri G., Marton L.F., Roberts J.D., Cobden P.M., Somogyi P. Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus. Neuroscience. 109:2002;63-80.
10. Dodd J., Kelly J.S. The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus. Brain Res. 205:1981;337-350.
11. Edelmann L., Hanson P.I., Chapman E.R., Jahn R. Synaptobrevin binding to synaptophysin: a potential mechanism for controlling the exocytotic fusion machine. EMBO J. 14(2):1995;224-231.
12. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates. 1997;Academic Press, London.
13. Fredens K., Stengaard-Pedersen K., Wallace M.N. Localization of cholecystokinin in the dentate commissural-associational system of the mouse and rat. Brain Res. 401:1987;68-78.
14. Freund T.F., Magloczky Z., Soltesz I., Somogyi P. Synaptic connections, axonal and dendritic patterns of neurons immunoreactive for cholecystokinin in the visual cortex of the cat. Neuroscience. 19:1986;1133-1159.
15. Freund T.F., Ylinen A., Miettinen R., Pitkanen A., Lahtinen H., Baimbridge K.G., Riekkinen P.J. Pattern of neuronal death in the rat hippocampus after status epilepticus relationship to calcium binding protein content and ischemic vulnerability . Brain Res Bull. 28:1992;27-38.
16. Fujise N., Liu Y., Hori N., Kosaka T. Distribution of calretinin immunoreactivity in the mouse dentate gyrus II. Mossy cells, with special reference to their dorsoventral difference in calretinin immunoreactivity . Neuroscience. 82:1998;181-200.
17. Gaarskjaer F.B. Organization of the mossy fiber system of the rat studied in extended hippocampi I. Terminal area related to number of granule and pyramidal cells . J Comp Neurol. 178:1978;49-72.
18. Gall C., Berry L.M., Hodgson L.A. Cholecystokinin in the mouse hippocampus localization in the mossy fiber and dentate commissural systems . Exp Brain Res. 62:1986;431-437.
19. Gall C., Brecha N., Karten H.J., Chang K.J. Localization of enkephalin-like immunoreactivity to identified axonal and neuronal populations of the rat hippocampus. J Comp Neurol. 198:1981;335-350.
20. Ghijsen W.E., Leenders A.G., Wiegant V.M. Regulation of cholecystokinin release from central nerve terminals. Peptides. 22:2001;1213-1221.
21. Gilbert M.E., Cain D.P. A single neonatal pertyleneletrazol or hyperthermia convulsion increases kindling susceptibility in the adult rat. Brain Res. 354:(2):1985;169-180.
22. Grabs D., Bergmann M., Schuster T., Fox P.A., Brich M., Gratz M. Differential expression of synaptophysin and synaptoporin during pre- and postnatal development of the rat hippocampal network. Eur J Neurosci. 6:1994;1765-1771.
23. Halonen T., Nissinen J., Pitkanen A. Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat. Epilepsy Res. 46:2001;205-223.
24. Hasegawa M., Usui H., Araki K., Kuwano R., Takahashi Y. Developmental and regional changes of cholecystokinin mRNA in rat brains. FEBS Lett. 194:1986;224-226.
25. Hörtnagl H., Berger M.L., Sperk G., Pifl C. Regional heterogeneity in the distribution of neurotransmitter markers in the rat hippocampus. Neuroscience. 45:1991;261-272.
26. Jinno S., Aika Y., Fukuda T., Kosaka T. Quantitative analysis of GABAergic neurons in the mouse hippocampus, with optical disector using confocal laser scanning microscope. Brain Res. 814:1998;55-70.
27. Jinno S., Aika Y., Fukuda T., Kosaka T. Quantitative analysis of neuronal nitric oxide synthase-immunoreactive neurons in the mouse hippocampus with optical disector. J Comp Neurol. 410:1999;398-412.
28. Jinno S., Kinukawa N., Kosaka T. Morphometric multivariate analysis of GABAergic neurons containing calretinin and neuronal nitric oxide synthase in the mouse hippocampus. Brain Res. 900:2001;195-204.
29. Jinno S., Ishizuka S., Kosaka T. Ionic currents underlying rhythmic bursting of ventral mossy cells in the developing mouse dentate gyrus. Eur J Neurosci. 17:2003;1338-1354.
30. Jinno S., Kosaka T. Colocalization of parvalbumin and somatostatin-like immunoreactivity in the mouse hippocampus quantitative analysis with optical disector . J Comp Neurol. 428:2000;377-388.
31. Jinno S., Kosaka T. Patterns of expression of calcium binding proteins and neuronal nitric oxide synthase in different populations of hippocampal GABAergic neurons in mice. J Comp Neurol. 449:2002;1-25.
32. Jinno S., Kosaka T. Patterns of expression of neuropeptides in GABAergic nonprincipal neurons in the mouse hippocampus quantitative analysis with optical disector . J Comp Neurol. 461:2003;333-349.
33. Kadar T., Pesti A., Penke B., Toth G., Zarandi M., Telegdy G. Structure-activity and dose-effect relationships of the antagonism of picrotoxin-induced seizures by cholecystokinin, fragments and analogues of cholecystokinin in mice. Neuropharmacology. 22:1983;1223-1229.
34. Kosaka T., Kosaka K., Tateishi K., Hamaoka Y., Yanaihara N., Wu J.Y., Hama K. GABAergic neurons containing CCK-8-like and/or VIP-like immunoreactivities in the rat hippocampus and dentate gyrus. J Comp Neurol. 239:1985;420-430.
35. Leenders A.G., Scholten G., Wiegant V.M., Da Silva F.H., Ghijsen W.E. Activity-dependent neurotransmitter release kinetics: correlation with changes in morphological distributions of small and large vesicles in central nerve terminals. Eur J Neurosci. 11:(12):1999;4269-4277.
36. Leranth C., Frotscher M. Synaptic connections of cholecystokinin- immunoreactive neurons and terminals in the rat fascia dentata a combined light and electron microscopic study . J Comp Neurol. 254:1986;51-64.
37. Liu Y., Fujise N., Kosaka T. Distribution of calretinin immunoreactivity in the mouse dentate gyrus I. General description . Exp Brain Bes. 108:1996;389-403.
38. Lorente de No R. Studies on the structure of the cerebral cortex II. Continuation of the study of the ammonic system . J Psychol Neurol. 46:1934;113-177.
39. Lothman E.W., Collins R.C. Kainic acid induced limbic seizures metabolic, behavioral, electroencephalographic and neuropathological correlates . Brain Res. 218:1981;299-318.
40. Marqueze-Pouey B., Wisden W., Malosio M.L., Betz H. Differential expression of synaptophysin and synaptoporin mRNAs in the postnatal rat central nervous system. J Neurosci. 11:1991;3388-3397.
41. McGinty J.F., Henriksen S.J., Goldstein A., Terenius L., Bloom F.E. Dynorphin is contained within hippocampal mossy fibers immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity . Proc Natl Acad Sci USA. 80:1983;589-593.
42. Morino P., Herrera-Marschitz M., Castel M.N., Ungerstedt U., Varro A., Dockray G., Hokfelt T. Cholecystokinin in cortico-striatal neurons in the rat immunohistochemical studies at the light and electron microscopical level . Eur J Neurosci. 6:1994;681-692.
43. Navone F., Jahn R., Di Gioia G., Stukenbrok H., Greengard P., De Camilli P. Protein p38 an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells . J Cell Biol. 103:(6 Pt 1):1986;2511-2527.
44. Nunzi M.G., Gorio A., Milan F., Freund T.F., Somogyi P., Smith A.D. Cholecystokinin-immunoreactive cells form symmetrical synaptic contacts with pyramidal and nonpyramidal neurons in the hippocampus. J Comp Neurol. 237:1985;485-505.
45. Okada M., Sakaguchi T., Kawasaki K. Correlation between anti-ubiquitin immunoreactivity and region-specific neuronal death in N-methyl-D-aspartate- treated rat hippocampal organotypic cultures. Neurosci Res. 22:1995;359-366.
46. Pawelzik H., Hughes D.I., Thomson A.M. Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin- positive interneurones in CA1 of the adult rat hippocampus. J Comp Neurol. 443:2002;346-367.
47. Racine R., Rose P.A., Burnham W.M. Afterdischarge thresholds and kindling rates in dorsal and ventral hippocampus and dentate gyrus. Can J Neurol Sci. 4:1977;273-278.
48. Schwarzer C., Sperk G., Samanin R., Rizzi M., Gariboldi M., Vezzani A. Neuropeptides-immunoreactivity and their mRNA expression in kindling functional implications for limbic epileptogenesis . Brain Res Brain Res Rev. 22:1996;27-50.
49. Shinohara S., Kawasaki K. Electrophysiological changes in rat hippocampal pyramidal neurons produced by cholecystokinin octapeptide. Neuroscience. 78:1997;1005-1016.
50. Sloviter R.S., Nilaver G. Immunocytochemical localization of GABA-, cholecystokinin-, vasoactive intestinal polypeptide-, and somatostatin-like immunoreactivity in the area dentata and hippocampus of the rat. J Comp Neurol. 256:1987;42-60.
51. Takeda K., Koshimoto H., Uchiumi F., Haun R.S., Dixon J.E., Kato T. Postnatal development of cholecystokinin-like immunoreactivity and its mRNA level in rat brain regions. J Neurochem. 53:1989;772-778.
52. Varro A., Bu'lock A.J., Williams R.G., Dockray G.J. Regional differences in the development of cholecystokinin-like activity in rat brain. Brain Res. 285:1983;347-352.
53. Zetler G. Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid. Neurosci Lett. 24:1981;175-180.